Los Angeles Capital Management’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $433K | Hold |
30,863
| – | – | ﹤0.01% | 910 |
|
|
2025
Q1 | $483K | Buy |
30,863
+70
| +0.2% | +$1.1K | ﹤0.01% | 753 |
|
|
2024
Q4 | $429K | Sell |
30,793
-94,310
| -75% | -$1.31M | ﹤0.01% | 847 |
|
|
2024
Q3 | $1.16M | Sell |
125,103
-10,845
| -8% | -$101K | ﹤0.01% | 604 |
|
|
2024
Q2 | $1.26M | Sell |
135,948
-12,485
| -8% | -$116K | ﹤0.01% | 572 |
|
|
2024
Q1 | $1.47M | Sell |
148,433
-46,028
| -24% | -$456K | 0.01% | 573 |
|
|
2023
Q4 | $628K | Buy |
+194,461
| New | +$628K | ﹤0.01% | 814 |
|
|
2022
Q2 | – | Sell |
-26,257
| Closed | -$506K | – | 1323 |
|
|
2022
Q1 | $506K | Sell |
26,257
-1,720
| -6% | -$33.1K | ﹤0.01% | 1019 |
|
|
2021
Q4 | $580K | Buy |
27,977
+7
| +0% | +$145 | ﹤0.01% | 936 |
|
|
2021
Q3 | $668K | Buy |
27,970
+1,280
| +5% | +$30.6K | ﹤0.01% | 925 |
|
|
2021
Q2 | $728K | Buy |
+26,690
| New | +$728K | ﹤0.01% | 1000 |
|